Bristol-Myers Squibb Company (VIE:BMYS)

Austria flag Austria · Delayed Price · Currency is EUR
47.60
-0.13 (-0.26%)
Last updated: Feb 4, 2026, 1:00 PM CET
-16.65%
Market Cap96.49B -13.0%
Revenue (ttm)40.94B +1.3%
Net Income5.15B
EPS2.53
Shares Outn/a
PE Ratio18.75
Forward PE9.71
Dividend2.15 (4.58%)
Ex-Dividend DateJan 2, 2026
Volumen/a
Average Volume10
Open47.43
Previous Close47.72
Day's Range47.43 - 47.60
52-Week Range36.69 - 58.44
Betan/a
RSI59.65
Earnings DateFeb 5, 2026

About VIE:BMYS

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Vienna Stock Exchange
Ticker Symbol BMYS
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements